文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
Keith H. Gibson and
发表
Studies Leading to the Identification of ZD1839 (Iressa): An Orally Active, Selective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Targeted to the Treatment of Cancer.
Keith H. Gibson and, 2010 .